"Creatinine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D003404
|
| MeSH Number(s) |
D03.383.129.308.207
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Creatinine".
Below are MeSH descriptors whose meaning is more specific than "Creatinine".
This graph shows the total number of publications written about "Creatinine" by people in this website by year, and whether "Creatinine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 5 | 5 |
| 1997 | 0 | 2 | 2 |
| 1999 | 0 | 3 | 3 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 6 | 7 |
| 2002 | 2 | 3 | 5 |
| 2003 | 1 | 7 | 8 |
| 2004 | 2 | 5 | 7 |
| 2005 | 1 | 6 | 7 |
| 2006 | 3 | 7 | 10 |
| 2007 | 1 | 7 | 8 |
| 2008 | 1 | 10 | 11 |
| 2009 | 1 | 11 | 12 |
| 2010 | 1 | 13 | 14 |
| 2011 | 2 | 7 | 9 |
| 2012 | 3 | 15 | 18 |
| 2013 | 2 | 9 | 11 |
| 2014 | 1 | 9 | 10 |
| 2015 | 2 | 5 | 7 |
| 2016 | 1 | 7 | 8 |
| 2017 | 0 | 5 | 5 |
| 2018 | 3 | 9 | 12 |
| 2019 | 4 | 9 | 13 |
| 2020 | 4 | 10 | 14 |
| 2021 | 2 | 8 | 10 |
| 2022 | 1 | 17 | 18 |
| 2023 | 0 | 10 | 10 |
| 2024 | 1 | 7 | 8 |
| 2025 | 0 | 8 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Creatinine" by people in Profiles.
-
Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR). Cardiovasc Diabetol. 2025 Dec 05; 24(1):454.
-
A multi-center collaborative highlights the differences in nephrotoxic medication exposure and associated AKI in pediatric bone marrow transplant, oncology, and pulmonary service lines. Pediatr Nephrol. 2026 Mar; 41(3):865-872.
-
Evaluation of coadministration schedules of rA1M for kidney protection after administration of 177Lu-octreotide. Radiat Prot Dosimetry. 2025 Aug 26; 201(13-14):995-1005.
-
eGFR Inaccuracy in the Assessment of Living Kidney Transplant Donor Eligibility. Clin Chem. 2025 Aug 01; 71(8):870-883.
-
Drug development studies supporting zileuton as a parenteral adjuvant to attenuate antibiotic-associated nephrotoxicity. Antimicrob Agents Chemother. 2025 08 06; 69(8):e0028725.
-
Albuminuria as a diagnostic criterion and a therapeutic target in heart failure and other cardiovascular disease. Eur J Heart Fail. 2025 Nov; 27(11):2357-2371.
-
Cardiovascular Disease Risk Estimates in the US CKD Population Using the PREVENT Equation. Am J Kidney Dis. 2025 Jul; 86(1):10-17.
-
Factors Associated With Long-term Kidney Allograft Survival: A Contemporary Analysis of the UNOS Database. Transplant Proc. 2025 Mar; 57(2):194-207.
-
Utility of urinary NT-proBNP in congenital diaphragmatic hernia: a prospective pilot study. Pediatr Res. 2025 Jun; 97(7):2305-2311.
-
Prospective evaluation of cystatin C in the assessment of kidney dysfunction and survival in liver transplant candidates. Liver Transpl. 2025 May 01; 31(5):571-583.